Repligen | RGEN - Selling And Administration Expenses


Repligen reported $74.36M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
Bio Techne USD 113.69M 2.52M Dec/2025
BioMarin Pharmaceutical USD 322.21M 98.79M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 383M 28M Dec/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Henry Schein USD 808M 48M Dec/2025
Illumina USD 283M 27M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Pfizer USD 4.08B 894M Dec/2025
Repligen USD 74.36M 703K Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Standard Biotools USD 21.55M 5.05M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 240.01M 25.78M Dec/2025
West Pharmaceutical Services USD 106.5M 3.8M Dec/2025